10-K: Universal Corporation Reports Strong Fiscal Year 2025 Revenue and Operating Income Growth Amidst EPS Decline and Internal Control Weakness

Sentiment:

Annual Report


Universal Corporation announced a 7% increase in consolidated revenues and a 5% rise in operating income for fiscal year 2025, driven by strong performance in both its Tobacco and Ingredients segments, despite a 21% drop in diluted earnings per share and the identification of a new material weakness in internal controls.

Worse than expectedDiluted earnings per share (as reported) decreased by 21% and adjusted diluted earnings per share (Non-GAAP) decreased by 9%, despite increases in revenue and operating income.The decline in net income was significantly impacted by a non-cash pension settlement charge of $14.1 million and a $13.4 million increase in interest expense.A new material weakness was identified in internal controls over financial reporting related to dark air-cured tobacco inventories, indicating a control deficiency that could lead to material misstatements.

Summary

  • Universal Corporation reported consolidated revenues of $2,947.3 million for fiscal year 2025, a 7% increase from $2,748.6 million in fiscal year 2024.
  • Consolidated operating income increased by 5% to $232.8 million in fiscal year 2025, up from $222.0 million in fiscal year 2024.
  • Adjusted operating income (Non-GAAP) rose by 6% to $243.4 million in fiscal year 2025, compared to $230.3 million in the prior year.
  • Diluted earnings per share (as reported) decreased by 21% to $3.78 in fiscal year 2025, down from $4.78 in fiscal year 2024.
  • Adjusted diluted earnings per share (Non-GAAP) fell by 9% to $4.63 in fiscal year 2025, from $5.08 in fiscal year 2024.
  • Tobacco Operations segment revenues grew by 7% to $2,608.7 million, with operating income increasing by 8% to $240.2 million.
  • Ingredients Operations segment revenues increased by 9% to $338.6 million, and operating income surged by 212% to $12.3 million.
  • The company generated $327.0 million in operating cash flows in fiscal year 2025, a significant improvement from a $74.6 million use in fiscal year 2024.
  • Net debt decreased by $179.6 million to $816.6 million, and the net debt to net capitalization ratio improved to 36% from 41%.
  • A new material weakness was identified in internal controls related to the physical counts and reconciliation of dark air-cured tobacco inventories at one subsidiary.
  • The company completed a non-cash pension de-risking transaction, resulting in a $14.1 million pension settlement charge in fiscal year 2025.
  • Interest expense increased by $13.4 million to $79.6 million due to higher average debt balances.
  • The consolidated effective tax rate for fiscal year 2025 was 26.6%, higher than the 19.0% in fiscal year 2024.

Sentiment

Score: 6

Explanation: The company demonstrated strong revenue and operating income growth across both segments, coupled with significant improvements in cash flow and debt metrics. However, the notable decline in diluted EPS, primarily due to a non-cash pension charge and higher interest expense, along with the identification of a new material weakness in internal controls, introduces significant concerns and uncertainty for investors.

Positives

  • Consolidated revenues increased by 7% to $2,947.3 million in fiscal year 2025, indicating strong top-line growth.
  • Consolidated operating income rose by 5% to $232.8 million, demonstrating improved operational efficiency.
  • Tobacco Operations segment delivered very strong results, with sales up 7% to $2,608.7 million and operating income up 8% to $240.2 million, driven by strong customer demand and successful global procurement.
  • Ingredients Operations segment showed exceptional growth, with sales up 9% to $338.6 million and operating income soaring by 212% to $12.3 million, benefiting from increased sales of value-added products and expanded capabilities.
  • Selling, general, and administrative expenses decreased by 2% to $305.3 million, partly due to higher recoveries of farmer advances and the absence of prior year tax settlement costs.
  • Operating cash flows significantly improved to $327.0 million in fiscal year 2025, compared to a $74.6 million cash use in the previous year, reflecting lower working capital requirements.
  • Net debt decreased by $179.6 million to $816.6 million, and the net debt to net capitalization ratio improved to 36% from 41%, indicating stronger financial health.
  • The company maintained a strong cash balance of $260.1 million at March 31, 2025.
  • Universal Corporation was in compliance with all financial covenants of its debt agreements as of March 31, 2025.
  • No long-term debt is maturing until fiscal year 2028, providing financial flexibility.
  • The company successfully remediated a previously disclosed material weakness related to embezzlement in Mozambique.
  • Continued commitment to sustainability, including a goal of net-zero greenhouse gas emissions by 2050 and extensive farmer training programs (1.8 million visits to over 175,000 contracted farmers).

Negatives

  • Diluted earnings per share (as reported) decreased by 21% to $3.78 in fiscal year 2025, despite revenue and operating income growth.
  • Adjusted diluted earnings per share (Non-GAAP) also declined by 9% to $4.63.
  • Gross profit margin decreased by 90 basis points to 18.6% in fiscal year 2025.
  • Tobacco Operations segment results were impacted by $13.4 million of higher tobacco inventory write-downs and weather-reduced crop sizes in Brazil and the United States.
  • Restructuring and impairment costs of $10.6 million were incurred in fiscal year 2025, primarily related to the consolidation of European tobacco sheet operations.
  • A non-cash pension settlement charge of $14.1 million was recognized in fiscal year 2025, impacting net income.
  • Interest expense increased by $13.4 million due to higher average debt balances.
  • The consolidated effective tax rate increased to 26.6% in fiscal year 2025 from 19.0% in fiscal year 2024, partly due to the mix of domestic and foreign earnings and minimal tax benefit from restructuring costs.
  • A new material weakness was identified in internal controls over financial reporting, specifically concerning the physical counts and reconciliation of dark air-cured tobacco inventories at one subsidiary.
  • The company is not currently eligible to use a Form S-3 registration statement due to previous late 10-Q filings, which could impair future capital-raising activities.

Risks

  • The company bears the risk that purchased tobacco may not meet customer quality and quantity requirements, potentially impacting profitability and recovery of crop advances.
  • Heavy reliance on a few large customers (top five account for over 50% of consolidated revenues), making the company vulnerable to loss of business or significant decreases in demand from these customers.
  • Financial results are significantly affected by changes in the balance of worldwide supply and demand for leaf tobacco, influenced by global consumption trends, competition, and regulatory factors.
  • Tobacco growing conditions, including weather, natural disasters, crop infestation, and climate change effects, can significantly alter financial results and processing schedules.
  • Major shifts in customer requirements for leaf tobacco supply could necessitate costly alterations to fixed assets, leading to restructuring and impairment charges or significant capital investments.
  • Inability to fully offset inflationary, tariff, and other cost pressures (e.g., raw products, packing materials, labor, energy, distribution) could materially and adversely affect business results.
  • Legal, regulatory, or other market measures to address climate change could lead to increased material and production costs or require additional capital investments for compliance.
  • The plant-based ingredients business is subject to industry-specific risks such as food spoilage/contamination, shifting consumer preferences, and product liability claims.
  • Disruption of the supply chain for plant-based ingredients due to various factors (e.g., weather, cyber-attacks, political instability) could impair production or sales.
  • Unsuccessful strategic investments or acquisitions, or failure to realize expected benefits due to integration difficulties and other challenges, could adversely affect financial condition.
  • Information technology system failures, including cybersecurity issues, could disrupt business operations and lead to financial and reputational damage.
  • Inability to attract, develop, retain, motivate, and maintain good relationships with its workforce, including key personnel and seasonal employees, could materially affect business and profitability.
  • Epidemics, pandemics, or similar widespread public health concerns could significantly disrupt economies, markets, and supply chains, negatively impacting the business.
  • Government efforts to regulate tobacco production and consumption (e.g., WHO FCTC, FDA regulations on nicotine levels, taxes) could significantly reduce demand for tobacco products and leaf.
  • Government actions on the sourcing of leaf tobacco, such as crop diversification initiatives, could create difficulties in sourcing leaf tobacco from certain regions.
  • Political and economic uncertainties in countries where the company operates internationally, particularly in developing and emerging markets, could adversely impact operations and asset recovery.
  • Increasing scrutiny and changing expectations from governments and stakeholders regarding sustainability considerations may impose additional costs or risks.
  • Changes in tax laws or their interpretation in the multiple jurisdictions where the company operates could have a material adverse effect on earnings and effective tax rate.
  • A material weakness in internal control over financial reporting related to dark air-cured tobacco inventories could lead to material misstatements if not remediated.
  • Ineligibility to use a Form S-3 registration statement due to prior late filings could impair capital-raising activities and increase transaction costs.
  • Failure of customers or suppliers to repay extensions of credit, particularly crop advances to farmers, could result in significant bad debt provisions.
  • Fluctuations in foreign currency exchange rates could materially impact results, especially for local currency-denominated costs and net monetary positions.
  • Changes in interest rates could increase net financing costs and affect pension plan liabilities and expense.

Future Outlook

Universal Corporation anticipates continued strong demand for tobacco in fiscal year 2026, with larger tobacco crops expected to shift global markets towards more balanced supply positions. Flue-cured tobacco production outside China is projected to increase by about 20%, and global burley tobacco production by about 35%. Oriental and dark air-cured tobacco production are also expected to increase by 9% and 6% respectively. The company foresees global tobacco production aligning with slowly declining total demand in the long term, with near-term global leaf tobacco demand expected to decline slowly in line with global cigarette consumption. Increased regulations requiring stringent monitoring and testing of leaf chemistry and compliant sourcing documentation are expected to further emphasize major sourcing areas. The FDA's proposed rule to lower nicotine levels in cigarettes could impact future leaf demand, though its implementation is expected to face legal challenges. The company plans capital expenditures of $45 to $55 million in fiscal year 2026 for maintenance and business improvements.

Management Comments

  • "Fiscal year 2025 was an exceptional year for Universal."
  • "We executed against our business plan and increased revenue and operating income on a consolidated basis and for both of our operating segments."
  • "The improved results for our Tobacco Operations segment were driven by continued strong demand from our customers, successful global tobacco marketing and procurement efforts, as well as improved volumes and quality of burley crops in Africa."
  • "Our Ingredients Operations segment benefited from higher sales volumes, including increases in sales of value-added products, supported by increased capabilities from the growth in our sales, marketing, and product development teams, and the completion of the expansion project at our Lancaster, Pennsylvania facility."
  • "We are very encouraged by the interest we are seeing from customers in our newly produced and developed value-added ingredient products."
  • "As we move into fiscal year 2026, we foresee continued strong demand for tobacco and larger tobacco crops shifting global markets to more balanced tobacco supply positions."
  • "We are also continuing our progress with Universal Ingredients and supporting existing and new customers with our platform resources and our expanded and enhanced ingredients facility."
  • "We are excited about the prospects for the year ahead as we seek to further maximize and optimize our tobacco business, grow our ingredients business, and strengthen our company to drive increasing value for all Universal stakeholders."
  • "Our goal is to drive excellence across the company and position Universal for long-term success and value creation."
  • "We believe that our leading position in the leaf tobacco industry is based on our volumes handled; our operating presence in all of the major sourcing areas; our ability to meet customer style, volume, and quality requirements; our experience in dealing with large numbers of farmers; our expertise in delivering a sustainable supply of compliant, traceable, competitively-priced leaf tobacco; and our long-standing relationships with customers."
  • "We believe our Tobacco Operations will continue to produce solid financial returns and enhance shareholder value through the following key operating principles: Strategic market position, Strong local management, Compliant products, Diversified sources, Financial strength."
  • "We believe that compliant leaf will continue to grow in importance to our customers and, as a result, will favor global suppliers who are able to deliver this product."
  • "We continue to support both governmental and industry efforts to eradicate illicit trade."
  • "Our commitment to sustainability remains at the core of our business, and we continue to implement what we believe are responsible sustainability practices."
  • "Universals business strategy integrates responsible business practices, and we believe our commitment to sustainability is a competitive advantage in the global marketplace."
  • "We believe that investing in human capital is critical to our continued success."
  • "We pride ourselves on a culture that respects co-workers and values concern for others."
  • "The health and safety of our employees is at the forefront of our business efforts."
  • "Our strategy is to deliver functional ingredients as well as convenience to our customers through customized solutions across the entire platform."

Industry Context

Universal Corporation operates in two distinct but related agriproducts sectors: leaf tobacco and plant-based ingredients. The tobacco industry is mature, experiencing a slow decline in global cigarette consumption (outside China, a compound annual rate of just over 1% for world consumption and about 2% for American-blend cigarettes over the five years ended 2023). This trend is exacerbated by increasing government regulation, including efforts by the WHO FCTC and the FDA to reduce tobacco consumption, limit nicotine levels, and ban flavors. The rise of next-generation tobacco products (ENDS, heated tobacco) presents an uncertain impact on traditional leaf demand. In response, Universal focuses on providing compliant, traceable leaf, supply chain efficiencies, and expanded services to customers. The plant-based ingredients market, in contrast, is a growth area driven by increasing consumer demand for healthy, transparent, and functional foods and beverages, as well as a growing pet food market. This market is highly fragmented, with many smaller competitors. Universal leverages its global sourcing capabilities and strong customer relationships to differentiate itself and offer customized solutions, aiming to capitalize on these growth trends through strategic investments and vertical integration opportunities.

Comparison to Industry Standards

  • Universal Corporation positions itself as one of only two major independent global competitors in the leaf tobacco industry, with Pyxus International, Inc. being its principal competitor.
  • Universal is uniquely positioned as the only global leaf tobacco supplier with operations in specific countries like the Dominican Republic, Ecuador, Hungary, Italy, Mexico, Mozambique, Paraguay, the Philippines, and Poland, and the only one participating in the sale and production of dark air-cured tobaccos.
  • The company estimates it has handled, on average over the last five years, between 20% and 30% of the annual flue-cured and burley tobacco production in Africa, 15% and 25% in Brazil, and 35% and 45% in the United States, demonstrating significant market share in key regions.
  • While major customers are partially vertically integrated and compete for leaf tobacco, Universal's ability to commercialize the entire tobacco plant and supply all major varieties provides a competitive advantage.
  • Universal distinguishes itself from smaller, opportunistic leaf tobacco competitors by providing extensive agronomic support, GAP and ALP programs, sustainability efforts, and quality controls, which add value for customers in an increasingly regulated environment despite potentially higher cost structures.
  • In the plant-based ingredients market, Universal differentiates itself from thousands of competitors, many of which are small, privately-owned, entrepreneurial companies lacking corporate support, by offering high-quality, innovative, customized product solutions with global sourcing capabilities and strong, long-standing customer relationships.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman, President, and Chief Executive OfficerN/AP. D. WignerOctober 1, 2024Election to new role; previously Senior Vice President since April 2024, Vice President since August 2007, and General Counsel and Secretary since November 2005.
General Counsel and SecretaryP. D. WignerC. H. ClaiborneApril 2024Election to new role; previously Vice President and Assistant Secretary from February 2018 to April 2024.
Vice President, IngredientsN/AJ. Patrick O'KeefeMay 2023Election to new role; also Senior Vice President of Universal Global Ventures, Inc. since April 1, 2020.
Senior Vice President and Sales Director (Universal Leaf Tobacco Company, Incorporated)N/AM. StarkeJuly 2023Election to new role; previously Senior Vice President since 2017, Vice President from January 2012 to February 2017, and Assistant Vice President from October 2007 to January 2012.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Committee Name ChangeThe Compensation Committee was renamed the Compensation and Human Resources Committee to reflect the increased importance of human capital management.N/AEnhances focus and oversight on human capital management, including compensation, benefits, retention, development, succession planning, and leadership development.
Oversight DelegationThe Board of Directors delegated primary oversight responsibility for the Information Security Program (including cybersecurity) to the Audit Committee.N/AStrengthens governance and oversight of critical cybersecurity risks and information security initiatives.
Policy AdoptionThe Board adopted a Code of Conduct and Anti-Corruption Compliance Manual, translated into 16 languages, applicable to all officers, directors, and non-seasonal employees.N/APromotes ethical behavior and addresses violations of ethical standards across the global organization.
Policy AdoptionThe Board adopted a Human Rights Policy, defining high ethical and social standards for global operations.N/AReinforces commitment to human rights and responsible business practices throughout the company's global footprint.
Internal Control DeficiencyA new material weakness was identified in internal controls over financial reporting related to the physical counts and reconciliation of dark air-cured tobacco inventories at one subsidiary.March 31, 2025Indicates a reasonable possibility of material misstatement in financial statements if not remediated; requires significant management attention and resources for corrective actions.
Internal Control RemediationThe previously disclosed material weakness related to embezzlement at the Mozambique subsidiary was successfully remediated as of March 31, 2025.March 31, 2025Positive step in strengthening internal controls and addressing prior deficiencies, including personnel changes and enhanced control activities.

Legal Proceedings

  • Subsidiaries are involved in litigation or legal matters incidental to their business activities, with outcomes uncertain but not currently expected to have a material adverse effect on the company's business or financial position.
  • In Brazil, the company's subsidiary received a new assessment for additional value-added tax (VAT) plus interest and penalties from the state of Parana, totaling approximately $3 million (at March 31, 2025 exchange rate) for periods from 2009 through 2014. Management and outside counsel believe the assessment is not supported by law and have challenged it, with a reasonably possible loss range of zero to $3 million, but no loss considered probable at this time.

Stakeholder Impact

  • **Shareholders**: Experienced a decline in diluted EPS despite revenue growth, but benefited from increased dividends and an active share repurchase program. The new material weakness in internal controls and ineligibility for Form S-3 could impact investor confidence and future capital raising.
  • **Employees**: Over 28,500 employees globally, with a commitment to an inclusive workplace, competitive compensation, and benefits. Talent development, training, and health & safety programs are in place. The successful remediation of the Mozambique embezzlement issue and the identification of a new material weakness in inventory controls highlight ongoing challenges and efforts in human capital management and operational integrity.
  • **Customers**: Benefited from strong customer demand for tobacco and increased sales of new value-added products in the Ingredients segment. The company continues to adapt its business model to meet evolving customer needs, providing compliant, traceable products and supply chain efficiencies.
  • **Suppliers (Farmers)**: The company maintains strong relationships with contracted farmers, providing agronomic support and seasonal crop advances. However, the company bears the risk of non-recovery of advances due to crop failures or delivery issues.
  • **Creditors**: The company's financial position improved with decreased net debt and an improved net debt to net capitalization ratio, and it remains in compliance with all financial covenants, indicating a stable credit profile.

Next Steps

  • The company plans to spend approximately $45 to $55 million in fiscal year 2026 on capital projects for maintenance and business improvements.
  • Universal will implement remediation steps for the newly identified material weakness in internal controls related to dark air-cured tobacco inventories, including enhanced documentation and additional reports for inventory reconciliation.
  • The company will continue to evaluate, interpret, and apply the new OECD Global Anti-Base Erosion Model Rules (Pillar Two) and monitor potential and enacted tax changes in jurisdictions where it operates.
  • Universal will continue to monitor industry developments regarding next-generation tobacco products, including consumer acceptance and regulation, and adapt its business model accordingly.
  • The company intends to continue to evaluate opportunities to return capital to shareholders, including through its authorized $100 million share repurchase program which expires November 15, 2026.
  • Universal intends to explore and develop targeted opportunities to vertically integrate certain plant-based ingredients from its tobacco growing areas to leverage existing strengths and capabilities.

Key Dates

DateDescription
2009U.S. Congress passed the Family Smoking Prevention and Tobacco Control Act (Tobacco Act).
2012WHO FCTC adopted an illicit trade protocol.
September 2014Parana tax authorities issued an initial assessment for VAT plus interest and penalties for periods from 2009 through 2014.
December 2015Parana tax authorities withdrew the initial claim and issued a new assessment for VAT.
May 10, 2016FDA released deeming regulations to extend FDA oversight over all tobacco products.
2017FDA announced a new regulatory approach for tobacco products, embracing a continuum of risk.
September 2018Johan C. Kroner elected Senior Vice President and Chief Financial Officer.
June 2019Scott J. Bleicher elected Vice President and Controller.
January 2020Acquisition of FruitSmart, Inc. completed.
April 1, 2020J. Patrick O'Keefe became Senior Vice President of Universal Global Ventures, Inc.
October 2020Acquisition of Silva International, Inc. completed.
October 2021Acquisition of Universal IngredientsShanks completed.
March 2022U.S. Congress extended FDA's authority to include regulation of synthetically manufactured nicotine.
December 2022Company entered into new receive-floating/pay-fixed interest rate swap agreements and new bank credit facility.
December 31, 2022Company adopted ASU 2020-04, Reference Rate Reform (Topic 848).
Fiscal Year Ended March 31, 2023Favorable final judgement from Brazilian Superior Court of Justice regarding tax credits; sale of idled Tanzania operations; net remeasurement gains of $3.9 million; net foreign currency transaction losses of $8.8 million; amortization expense for intangible assets was $12,455 thousand; total stock-based compensation expense was $8,419 thousand; capital expenditures were $54,674 thousand; employer defined contribution savings plans expense was $3.4 million.
May 2023J. Patrick O'Keefe elected Vice President, Ingredients.
July 2023M. Starke elected Senior Vice President and Sales Director of Universal Leaf Tobacco Company, Incorporated.
August 1, 2023Company's 2023 Stock Incentive Plan approved by shareholders.
October 2, 2023Universal Corporation Dodd-Frank Clawback Policy became effective.
November 2023FASB issued ASU No. 2023-07, Segment Reporting (Topic 280).
December 20, 2023Original maturity date for prior five-year term loan interest rate swap agreement.
Fiscal Year Ended March 31, 2024Company incurred $1.8 million restructuring and impairment costs for GLS facility; net remeasurement losses of $5.1 million; net foreign currency transaction losses of $3.2 million; amortization expense for intangible assets was $11,279 thousand; total stock-based compensation expense was $12,063 thousand; capital expenditures were $66,013 thousand; employer defined contribution savings plans expense was $4.3 million; total debt was $1,034,581 thousand; net debt was $996,167 thousand; net capitalization was $2,433,374 thousand; net debt to net capitalization was 41%; cash and cash equivalents were $55,593 thousand; uncommitted tobacco inventories were $181,100 thousand (17% of tobacco inventory); recoverable tax credits were $72 million with $21 million allowance; pension plan assets were $220 million with PBO of $238 million.
February 2024Tenth Conference of the Parties (FCTC) held.
April 2024C. H. Claiborne elected General Counsel and Secretary.
August 2024Company's management became aware of embezzlement by a former senior finance employee at Mozambique subsidiary.
December 2024Universal released its 2024 Sustainability Report.
January 1, 2024Effective enactment date for OECD Pillar Two rules in certain jurisdictions.
January 2025FDA released a proposed rule to lower nicotine levels in cigarettes.
March 2025Company completed a pension de-risking transaction (pension lift-out) to transfer approximately $47 million of obligations and assets.
March 31, 2025Fiscal year end; total common stock outstanding was 24,715,625 shares; total debt was $1,072,957 thousand; net debt was $816,605 thousand; net capitalization was $2,275,161 thousand; net debt to net capitalization was 36%; cash and cash equivalents were $260,115 thousand; uncommitted tobacco inventories were $164,000 thousand (20% of tobacco inventory); recoverable tax credits were $64 million with $21 million allowance; pension plan assets were $171 million with PBO of $188 million; total notional amount of interest rate swaps was $310 million; fair value of open interest rate hedge swaps was a net asset of $2 million; fair value of open foreign currency cash flow hedge contracts was a net liability of $5.2 million; fair value of other forward contracts was a net liability of $1.1 million; total contingent liabilities were $1.0 million.
April 17, 2025Amended and Restated Bylaws became effective.
May 29, 2025Total number of shares of common stock outstanding was 24,715,625.
May 30, 2025Filing date of the Annual Report on Form 10-K; Compensation and Human Resources Committee granted Airton L. Hentschke a special award of 22,050 restricted stock units.
August 5, 2025Expected date of the 2025 Annual Meeting of Shareholders.
November 2025Eleventh Conference of the Parties (COP) of the WHO FCTC is scheduled.
December 15, 2024Effective date for ASU 2023-09 (Income Taxes) for fiscal years beginning after this date.
March 1, 2026Earliest date for potential restoration of Form S-3 registration statement eligibility.
Fiscal Year 2026Company plans to spend approximately $45 to $55 million on capital projects; no contributions expected to ERISA-regulated pension plan; $11.3 million expected contributions to non-ERISA regulated pension plans; flue-cured tobacco production outside China projected to increase by about 20%; global burley tobacco crop projected to increase by about 35%; oriental tobacco production projected to increase by about 9%; dark air-cured tobacco production projected to increase by about 6%.
November 15, 2026Expiration date of the current $100 million share repurchase program.
December 15, 2026Effective date for ASU 2024-03 (Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures) for fiscal years beginning after this date.
December 2027Maturity date of the $530 million five-year revolving credit facility and the $275 million five-year term loan.
Fiscal Year 2028No long-term debt maturing until this fiscal year.
December 15, 2027Effective date for ASU 2024-03 (Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures) for interim periods beginning after this date.
December 15, 2029Maturity date of the $345 million seven-year term loan.
2050Company's goal of reaching net-zero greenhouse gas (GHG) emissions across the value chain.

Recommendation

hold

Keywords

Tobacco, Leaf Tobacco, Agriproducts, Plant-based Ingredients, Food Ingredients, Beverage Ingredients, Supply Chain, Sustainability, SEC Filing, 10-K, Financial Results, Operating Income, Earnings Per Share, Internal Controls, Risk Management, Corporate Governance, Global Operations, Crop Production, Agricultural Practices, Human Capital Management, Cybersecurity, Pension, Debt Management, Capital Allocation, Share Repurchase, Regulatory Compliance, FDA, WHO FCTC, International Trade, Emerging Markets

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.